【摘 要】
：
A "hybrid strategy" combines treatments traditionally only available in the catheterization lab with those traditionally only available in the operating room, to offer patients the best available comb
【机 构】
：
Pinnacle Health Cardiovascular Institute / Internal Medicine Pinnacle Health Hospitals USA
【出 处】
：
BIT`s 4th Annual International Congress of Cardiology-2012(2
论文部分内容阅读
A "hybrid strategy" combines treatments traditionally only available in the catheterization lab with those traditionally only available in the operating room, to offer patients the best available combination of treatments and potentially limiting morbidity and mortality.
其他文献
Stabilization of the ruptured or unstable plaque is the next major therapeutic target for improving outcomes for patients with acute coronary syndromes.Intravascular imaging techniques including virtu
Athersosclerotic cardiovascular disease has its origins in childhood and is a lifelong process.As such, identification of risk factors, early treatment and prevention of long term exposure to risk fac
Artificially oxidized low-density lipoprotein (LDL) is known for its atherogenic effects on vascular cells in culture, but a naturally-occurring LDL with equivalent chemical and physical characteristi
Background Conventional coronary artery bypass grafting (CCABG), performed with the use of cardiopulmonary bypass, is a well-validated treatment of patients with ischemic heart disease.
Drug-eluting stents significantly reduce the incidence of in-stent restenosis, which was once considered a major adverse outcome of percutanous coronary stent implantation.Localized release of antipro
Coronary bifurcations are by nature prone to the development of atherosclerosis.They pose technical difficulties for percutaneous coronary angioplasty treatment and they are associated with higher ste
[Background] Due to reduced restenosis rate after Drug-eluting stents implantation (DES) and improved skills, we must manage patients with counterfeit non-stenotic coronary trees.Although endothelial
Coronary perforation is one of the most challenging and feared complications of percutaneous coronary intervention (PCI).Coronary perforation has been classified by Ellis et al.
PCI for unprotected left main coronary artery (ULMCA) lesions has a class Ⅱb indication according to recent guidelines.In this challenging subset of patients, PCI with drug eluting stent (DES) implant
Drug-eluting stent (DES) have been playing a leading role in percutaneous coronary intervention (PCI) all over the world.With the advent of DES, restenosis, which had been a major problem after classi